Listed Mainboard

Symbiotec Pharmalab IPO Subscription Status

Q: What is the current subscription status of Symbiotec Pharmalab IPO?

As of IPO close date (27 Aug, 2026), the Symbiotec Pharmalab IPO is subscribed 71.26x times. Retail category is 12.96x, and NII is 73.63x subscribed.

Q: When is the allotment date for Symbiotec Pharmalab IPO?

The allotment for Symbiotec Pharmalab IPO is expected to be finalized on 28 August, 2026.

Q: What is the GMP of Symbiotec Pharmalab?

The Grey Market Premium (GMP) for Symbiotec Pharmalab is currently ₹185, indicating a potential listing gain of 18.72%.

Q: When will Symbiotec Pharmalab IPO list on the stock market?

Symbiotec Pharmalab is scheduled to list on BSE and NSE on 01 September, 2026.

Q: What are the chances of getting allotment in Symbiotec Pharmalab IPO?

The retail category is oversubscribed at 12.96x, meaning allotment is by lottery. Statistically, approximately 1 in 13 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

Q: What does QIB subscription of 172.03x mean for Symbiotec Pharmalab IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 172.03x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

Q: How to check Symbiotec Pharmalab IPO allotment status?

After the allotment date (28 Aug, 2026), you can check your Symbiotec Pharmalab IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Symbiotec Pharmalab IPO was subscribed 71.26 times when bidding closed on 27 Aug 2026: QIB 172.03x, NII 73.63x, Retail 12.96x.

The Symbiotec Pharmalab IPO has been subscribed 71.26x times overall. Retail investors have shown interest with bids for 12.96x the shares available. The Non-Institutional Investor (NII) category has been subscribed 73.63x. Within NII, Big HNI (B-HNI) subscribed 82.92x and Small HNI (S-HNI) subscribed 55.07x. Qualified Institutional Buyers (QIBs) have subscribed 172.03x. Data last updated on 08 Sep, 01:37 PM.

The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 24 Aug, 2026 and closes on 27 Aug, 2026. The shares are expected to list on stock exchanges on 01 Sep, 2026.

Full details Check GMP

Final subscription

71.26x

51,73,193 applications

Category-wise bids →

QIB

172.03x

Institutions · proportionate allotment

Why QIB matters →

NII / HNI

73.63x

bNII 82.92x · sNII 55.07x

HNI allotment odds →

Retail

12.96x

Lottery for 1 lot — about 1 in 13

Retail allotment odds →

Employee

15.41x

Employee reservation

Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated 8 Sep 2026, 1:37 PM IST Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Switch to Detailed for the exchange's own sub-category rows.

Category	Offered	Applied	Amount (Cr)	Bid details	Times
QIB	37,39,872	64,33,59,195	63,563.89 Cr	64,33,59,195 of 37,39,872 226 applications 63,563.89 Cr	172.03x
1(a) Foreign Institutional Investors (FIIs)		12,59,47,230	12,443.59 Cr	12,59,47,230 12,443.59 Cr
1(b) Domestic Financial Institutions (Banks/FIs/Insurance)		36,76,69,110	36,325.71 Cr	36,76,69,110 36,325.71 Cr
1(c) Mutual Funds		3,49,90,815	3,457.09 Cr	3,49,90,815 3,457.09 Cr
1(d) Others		11,47,52,040	11,337.50 Cr	11,47,52,040 11,337.50 Cr
NII	28,04,904	20,65,35,120	20,405.67 Cr	20,65,35,120 of 28,04,904 3,85,632 applications 20,405.67 Cr	73.63x
2.1 Big NII — bid amount above ₹10 Lakh	18,69,936	15,50,46,495	15,318.59 Cr	15,50,46,495 1,49,636 applications 15,318.59 Cr	82.92
2.1(a) Corporates		12,53,805	123.88 Cr	12,53,805 123.88 Cr
2.1(b) Individuals (other than RIIs)		14,63,23,875	14,456.80 Cr	14,63,23,875 14,456.80 Cr
2.1(c) Others		74,68,815	737.92 Cr	74,68,815 737.92 Cr
2.2 Small NII — bid amount ₹2–10 Lakh	9,34,968	5,14,88,625	5,087.08 Cr	5,14,88,625 2,35,996 applications 5,087.08 Cr	55.07
2.2(a) Corporates		1,44,720	14.30 Cr	1,44,720 14.30 Cr
2.2(b) Individuals (other than RIIs)		4,95,61,725	4,896.70 Cr	4,95,61,725 4,896.70 Cr
2.2(c) Others		17,82,180	176.08 Cr	17,82,180 176.08 Cr
Retail	65,44,776	8,48,10,330	8,379.26 Cr	8,48,10,330 of 65,44,776 47,86,759 applications 8,379.26 Cr	12.96x
Employee	35,377	5,45,055	53.85 Cr	5,45,055 of 35,377 576 applications 53.85 Cr	15.41x
TOTAL	1,31,24,929	93,52,49,700	92,402.67 Cr	93,52,49,700 51,73,193 applications 92,402.67 Cr	71.26x

Symbiotec Pharmalab IPO Basis of Allotment

Final Final figures published by the registrar, after technical rejections. Allotment price ₹988, employees ₹898.

Applications

51,73,227

Allottees

4,27,704

Overall odds

1 in 12

Amount collected

₹92,529 Cr

Category	AppsApplications	Shares Applied	Shares Allotted	GotAllottees	Odds
QIB 72.96x subscribed	260	64,76,29,440 ₹63,985 Cr	88,76,516 72.96x subscribed	260	AllAll allotted
Ex. Anchor Ex. Anchor	226	64,21,33,275	35,50,607 · 180.85x	226	AllAll allotted
Anchor Anchor Investors	34	54,96,165	53,25,909 · 1.03x	34	AllAll allotted
NII (HNI) 77.22x subscribed	3,85,632	20,56,38,555 ₹20,317 Cr	26,62,956 77.22x subscribed	12,679	1 in 301 in 30
bNII >₹10L bNII — above ₹10 Lakh	1,49,636	15,44,87,460	17,75,304 · 87.02x	8,453	1 in 181 in 18
sNII <₹10L sNII — below ₹10 Lakh	2,35,996	5,11,51,095	8,87,652 · 57.63x	4,226	1 in 561 in 56
Retail 13.42x subscribed	47,86,759	8,33,71,905 ₹8,237 Cr	62,13,563 13.42x subscribed	4,14,237	1 in 121 in 12
Employees 1.53x subscribed	576	50,970 ₹4 Cr	33,407 1.53x subscribed	528	1 in 1.11 in 1.1
TOTAL 52.66x subscribed	51,73,227	93,66,90,870	1,77,86,442 52.66x subscribed	4,27,704	1 in 121 in 12

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 7.7% for a single lot.

Institutional Backing

Massive institutional interest with QIBs subscribing 172.03x. This often signals long-term confidence from professional funds.

Day-wise subscription history

End-of-day subscription across the 4-day bidding window. On phones, tap a day for the category split.

Date	Total	QIB	BHNI	SHNI	Retail	Employee
27 Aug 2026 Day 4	71.26x	172.03x	82.92x	55.07x	12.96x	15.41x	▼
QIB172.03x BHNI82.92x SHNI55.07x Retail12.96x Employee15.41x
26 Aug 2026 Day 3	5.32x	0.62x	11.3x	13.95x	5.05x	5.86x	▼
QIB0.62x BHNI11.3x SHNI13.95x Retail5.05x Employee5.86x
25 Aug 2026 Day 2	1.85x	0.54x	2.45x	4.07x	2.1x	3.01x	▼
QIB0.54x BHNI2.45x SHNI4.07x Retail2.1x Employee3.01x
24 Aug 2026 Day 1	0.8x	0.35x	0.78x	1.58x	0.95x	1.56x	▼
QIB0.35x BHNI0.78x SHNI1.58x Retail0.95x Employee1.56x

Symbiotec Pharmalab IPO dates

From the bidding window to listing. Today is 4 October.

Key dates Listed

Open 24 Aug 2026
Close 27 Aug 2026
Allotment 28 Aug 2026
Refund/credit 31 Aug 2026
Listing 01 Sep 2026

Anchor investor allocation

Shares allotted to anchor investors the working day before the issue opened.

#	Anchor Investor	Group Entity	Shares Allotted	Amt (₹ cr.)	% Allocated	% of Issue
1	ICICI PRUDENTIAL SMALLCAP FUND	ICICI PRUDENTIAL MUTUAL FUND	607290	₹60.00 Cr	11.40%	3.41%
2	ASHOKA WHITEOAK ICAV-ASHOKA WHITEOAK EMERGING MARKETS EQUITY FUND	ASHOKA WHITEOAK	455475	₹45.00 Cr	8.55%	2.56%
3	MOTILAL OSWAL SMALL CAP FUND	MOTILAL OSWAL MUTUAL FUND	455475	₹45.00 Cr	8.55%	2.56%
4	HDFC PHARMA & HEALTHCARE FUND	HDFC MUTUAL FUND	404865	₹40.00 Cr	7.60%	2.28%
5	MIRAE ASSET HEALTHCARE FUND	MIRAE ASSET MUTUAL FUND	354270	₹35.00 Cr	6.65%	1.99%
6	PRAZIM TRADING & INVESTMENT CO.PVT.LTD.	PRAZIM TRADING & INVESTMENT	253050	₹25.00 Cr	4.75%	1.42%
7	MANULIFE GLOBAL FUND-INDIA EQUITY FUND	MANULIFE	253050	₹25.00 Cr	4.75%	1.42%
8	MAHINDRA MANULIFE SMALL CAP FUND	MAHINDRA MANULIFE MUTUAL FUND	253050	₹25.00 Cr	4.75%	1.42%
9	EDELWEISS LARGE CAP FUND	EDELWEISS MUTUAL FUND	202425	₹20.00 Cr	3.80%	1.14%
10	TATA AIA LIFE INSURANCE CO.LTD.-WHOLE LIFE AGGRESSIVE GROWTH FUND-ULIF 010 04/01/07 WLA 110	TATA AIA LIFE INSURANCE	161955	₹16.00 Cr	3.04%	0.91%
11	BAJAJ LIFE INSURANCE LTD.	BAJAJ LIFE INSURANCE	161955	₹16.00 Cr	3.04%	0.91%
12	TATA FLEXI CAP FUND	TATA MUTUAL FUND	151830	₹15.00 Cr	2.85%	0.85%
13	BARODA BNP PARIBAS FOCUSED FUND	BARODA BNP PARIBAS MUTUAL FUND	101235	₹10.00 Cr	1.90%	0.57%
14	TATA INDIA PHARMA & HEALTHCARE FUND	TATA MUTUAL FUND	101220	₹10.00 Cr	1.90%	0.57%
15	BHARTI AXA LIFE INSURANCE CO.LTD.	BHARTI AXA LIFE INSURANCE	101220	₹10.00 Cr	1.90%	0.57%
16	TIMF HOLDINGS	TIMF HOLDINGS	101220	₹10.00 Cr	1.90%	0.57%
17	VALUEQUEST FOUNDERS CONVICTION LVF	VALUEQUEST	101220	₹10.00 Cr	1.90%	0.57%
18	SUSQUEHANNA PACIFIC PTY.LTD.	SUSQUEHANN	101220	₹10.00 Cr	1.90%	0.57%
19	SINGULARITY EQUITY FUND I	SINGULARITY	101220	₹10.00 Cr	1.90%	0.57%
20	MIRAE ASSET MULTI ASSET ALLOCATION FUND	MIRAE ASSET MUTUAL FUND	101205	₹10.00 Cr	1.90%	0.57%
21	ICICI LOMBARD GENERAL INSURANCE CO.LTD.	ICICI LOMBARD GENERAL INSURANCE	88331	₹8.73 Cr	1.66%	0.50%
22	BNP PARIBAS FINANCIAL MARKETS-ODI	BNP PARIBAS	88330	₹8.73 Cr	1.66%	0.50%
23	GROWW MULTICAP FUND	GROWW MUTUAL FUND	70860	₹7.00 Cr	1.33%	0.40%
24	BARODA BNP PARIBAS HEALTH & WELLNESS FUND	BARODA BNP PARIBAS MUTUAL FUND	60720	₹6.00 Cr	1.14%	0.34%
25	CITIGROUP GLOBAL MARKETS MAURITIUS PVT.LTD.	CITIGROUP	57963	₹5.73 Cr	1.09%	0.33%
26	EDELWEISS RECENTLY LISTED IPO FUND	EDELWEISS MUTUAL FUND	50625	₹5.00 Cr	0.95%	0.28%
27	HDFC MNC FUND	HDFC MUTUAL FUND	50610	₹5.00 Cr	0.95%	0.28%
28	TRUST MF MULTI CAP FUND	TRUST MUTUAL FUND	50610	₹5.00 Cr	0.95%	0.28%
29	TRUST MF LARGE & MID CAP FUND	TRUST MUTUAL FUND	50610	₹5.00 Cr	0.95%	0.28%
30	FLUMEN INVESTMENT TRUST-1729 GROWTH FUND I	FLUMEN INVESTMENT	50610	₹5.00 Cr	0.95%	0.28%
31	RMS GROWTH FUND SCHEME I	RMS	50610	₹5.00 Cr	0.95%	0.28%
32	ITI MULTI CAP FUND	ITI MUTUAL FUND	50610	₹5.00 Cr	0.95%	0.28%
33	ITI FLEXI CAP FUND	ITI MUTUAL FUND	50610	₹5.00 Cr	0.95%	0.28%
34	GROWW SMALL CAP FUND	GROWW MUTUAL FUND	30360	₹3.00 Cr	0.57%	0.17%
	TOTAL		5,325,909	₹526.19 Cr	99.98%

Symbiotec Pharmalab IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)

1 in 11

~9.1% chance per PAN — 4,786,759 applicants for 436,318 allotment slots. Winners get exactly 1 lot (₹14,820) by SEBI lottery, however many lots you bid.

Small HNI (₹2–10 L)

1 in 54

~1.9% chance — 235,996 applicants for 4,452 allotment slots. Lottery allots the minimum S-HNI application of 14 lots (₹2.1 L) per winner; bidding bigger doesn't improve odds.

Big HNI (above ₹10 L)

1 in 82

~1.2% chance — 149,636 applicants for 1,833 allotment slots. Lottery allots the minimum B-HNI application of 68 lots (₹10.1 L) per winner; the rest is proportionate.

QIB (institutions)

172.03x

Proportionate allotment — at 172.03x, institutions receive ~0.6% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds marked with applicant counts are computed from the exchange's actual application data (applicants ÷ allotment slots); others assume minimum-size bids at the current subscription multiple. Retail and HNI allotment is by SEBI-mandated lottery of the minimum application when oversubscribed; QIB allotment is proportionate. Numbers move until subscription closes. This is not investment advice.

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Symbiotec Pharmalab IPO?

As of IPO close date (27 Aug, 2026), the Symbiotec Pharmalab IPO is subscribed 71.26x times. Retail category is 12.96x, and NII is 73.63x subscribed.

When is the allotment date for Symbiotec Pharmalab IPO?

The allotment for Symbiotec Pharmalab IPO is expected to be finalized on 28 August, 2026.

What is the GMP of Symbiotec Pharmalab?

The Grey Market Premium (GMP) for Symbiotec Pharmalab is currently ₹185, indicating a potential listing gain of 18.72%.

When will Symbiotec Pharmalab IPO list on the stock market?

Symbiotec Pharmalab is scheduled to list on BSE and NSE on 01 September, 2026.

What are the chances of getting allotment in Symbiotec Pharmalab IPO?

The retail category is oversubscribed at 12.96x, meaning allotment is by lottery. Statistically, approximately 1 in 13 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 172.03x mean for Symbiotec Pharmalab IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 172.03x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Symbiotec Pharmalab IPO allotment status?

After the allotment date (28 Aug, 2026), you can check your Symbiotec Pharmalab IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Symbiotec Pharmalab IPO further

Track every stage of this IPO, from subscription to listing.

01 Next step

IPO details

It has listed — go back to the fundamentals.

₹938 to ₹988

Read the full profile

GMP today

Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.

GMP ₹185 (18.72%)

See the grey market

IPO review

What brokers and analysts are saying about this issue, in one place.

Strong Apply · 12 reviews

See the verdicts

Allotment status

Check with your PAN whether shares were credited to your demat account.

Allotment out · 28 Aug

Check my allotment

IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total

71.26x

QIB

172.03x

NII

73.63x

Retail

12.96x

Full IPO details